Jianchao Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jianchao Ma has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Yongyu Chen
Department of Hematology, Minzu Hospital of Guangxi Medical University, Nanning, China
3 shared publications - Bin Liang
Department of Gastroenterology, Minzu Hospital of Guangxi Medical University, Nanning, China
2 shared publications - Jiansheng Huang
Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530000, China
2 shared publications - Xue Qiu
Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
2 shared publications - Yequan Lu
Department of Respiratory, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin, Guangxi 541000, China
2 shared publications Bin Liang
Department of Gastroenterology, Minzu Hospital of Guangxi Medical University, Nanning, China
1 shared publication
Latest Publications
- Open Access
- 13 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (7) , e47599
Geriatric nutritional risk index is associated with erectile dysfunction
An essential instrument for evaluating older adults’ nutritional status is the geriatric nutritional risk index (GNRI). This investigation aimed to examine the connection between the GNRI and erectile dysfunction (ED) risk. Three models were created, and the connection between GNRI and ED was investigated through multiple linear and logistic regressions. The nonlinear relationship between GNRI and ED was evaluated using smooth curve fitting. To further confirm the consistency of GNRI and ED relationships across various populations, subgroup analysis, interaction tests, and sensitivity analyses were employed. The receiver operating characteristic curve was applied to evaluate how well GNRI could forecast the occurrence of ED. Among 1898 participants, GNRI was negatively associated with the risk of ED occurrence. In the fully adjusted model, the risk of ED decreases by 4% (OR = 0.96, 95% CI 0.94–0.99, P = .0032) for every 1-unit rise in GNRI. Compared with the low GNRI group ( .05). The sensitivity analysis and the receiver operating characteristic curve (with an area under curve of 0.651) demonstrate GNRI’s good predictive ability. A higher GNRI was significantly associated with a lower risk of ED occurrence. The GNRI is a reliable, independent predictor of ED occurrence in older adults.
- 13 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (7) , e47599
Open AccessGeriatric nutritional risk index is associated with erectile dysfunction
An essential instrument for evaluating older adults’ nutritional status is the geriatric nutritional risk index (GNRI). This investigation aimed to examine the connection between the GNRI and erectile dysfunction (ED) risk. Three models were created, and the connection between GNRI and ED was investigated through multiple linear and logistic regressions. The nonlinear relationship between GNRI and ED was evaluated using smooth curve fitting. To further confirm the consistency of GNRI and ED relationships across various populations, subgroup analysis, interaction tests, and sensitivity analyses were employed. The receiver operating characteristic curve was applied to evaluate how well GNRI could forecast the occurrence of ED. Among 1898 participants, GNRI was negatively associated with the risk of ED occurrence. In the fully adjusted model, the risk of ED decreases by 4% (OR = 0.96, 95% CI 0.94–0.99, P = .0032) for every 1-unit rise in GNRI. Compared with the low GNRI group ( .05). The sensitivity analysis and the receiver operating characteristic curve (with an area under curve of 0.651) demonstrate GNRI’s good predictive ability. A higher GNRI was significantly associated with a lower risk of ED occurrence. The GNRI is a reliable, independent predictor of ED occurrence in older adults.
- Open Access
- 1 January 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (1) , 101620
Bioinformatic validation and machine learning based exploration of B cells-related gene signatures in the context of strategies for precision therapy to acute myeloid leukemia
- 1 January 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (1) , 101620
Open AccessBioinformatic validation and machine learning based exploration of B cells-related gene signatures in the context of strategies for precision therapy to acute myeloid leukemia
- 16 June 2025
- Published by Springer Nature in Mammalian Genome
- Vol. 36 (3) , 735-745
Single-cell and bulk RNA sequencing reveals specific Trem2 positive B cell subtype niche after myocardial infarction in mice
This study aims to characterize B cell subtypes in mice following myocardial infarction (MI) and identify potential therapeutic targets for adverse remodeling post-MI. The scRNA-seq (GSE163129) and bulk RNA sequencing data (GSE19322) of mice post-MI were obtained from the GEO database. Seurat, gene set enrichment analysis, SCENIC analysis, Monocle 2 and NichNet analysis were performed in scRNA-seq data. Only the changes of immune cell populations in the infarct areas at different points after MI and pre - MI (steady - state) condition were compared. Bulk RNA-seq data for myocardium of post-MI in mice was used for validation. Twelve cell types were identified on scRNA-seq data and B cells were divided into five subtypes including B_Trem2 and others. B_Trem2 exhibited regulatory B (Breg) cells characteristics, displaying expressions of the cardiac repair gene Trem2, the anti-inflammatory marker Il10, and the myocardial remodeling molecule Spp1. B_Trem2 activated anti-inflammatory pathways. Nfe2l2, Rxrb, Zfp672, Prdm1 and Hivep3 were activated in the B_Trem2 subtype occupying the terminal stage of B cell development. Apoe was a potential activator of Spp1 overexpression in B_Trem2. Receptors of Apoe, namely Lrp1, Sdc4, and Sdc3, exhibited elevated expression within B_Trem2 subtype. This study identified a specific B cell subtype (B_Trem2) with Breg characteristics that overexpressed Spp1 in post- MI mice. Apoe may promote Spp1 expression in B_Trem2, by binding Apoe to Lrp1, Sdc4 and Sdc3 receptors on B_Trem2. This provides a new therapeutic target for MI.
- 16 June 2025
- Published by Springer Nature in Mammalian Genome
- Vol. 36 (3) , 735-745
Single-cell and bulk RNA sequencing reveals specific Trem2 positive B cell subtype niche after myocardial infarction in mice
This study aims to characterize B cell subtypes in mice following myocardial infarction (MI) and identify potential therapeutic targets for adverse remodeling post-MI. The scRNA-seq (GSE163129) and bulk RNA sequencing data (GSE19322) of mice post-MI were obtained from the GEO database. Seurat, gene set enrichment analysis, SCENIC analysis, Monocle 2 and NichNet analysis were performed in scRNA-seq data. Only the changes of immune cell populations in the infarct areas at different points after MI and pre - MI (steady - state) condition were compared. Bulk RNA-seq data for myocardium of post-MI in mice was used for validation. Twelve cell types were identified on scRNA-seq data and B cells were divided into five subtypes including B_Trem2 and others. B_Trem2 exhibited regulatory B (Breg) cells characteristics, displaying expressions of the cardiac repair gene Trem2, the anti-inflammatory marker Il10, and the myocardial remodeling molecule Spp1. B_Trem2 activated anti-inflammatory pathways. Nfe2l2, Rxrb, Zfp672, Prdm1 and Hivep3 were activated in the B_Trem2 subtype occupying the terminal stage of B cell development. Apoe was a potential activator of Spp1 overexpression in B_Trem2. Receptors of Apoe, namely Lrp1, Sdc4, and Sdc3, exhibited elevated expression within B_Trem2 subtype. This study identified a specific B cell subtype (B_Trem2) with Breg characteristics that overexpressed Spp1 in post- MI mice. Apoe may promote Spp1 expression in B_Trem2, by binding Apoe to Lrp1, Sdc4 and Sdc3 receptors on B_Trem2. This provides a new therapeutic target for MI.
- Open Access
- 3 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a globally widespread chronic liver condition that may progress to severe liver diseases, including advanced liver fibrosis. The high-sensitivity C-reactive protein-to-high-density lipoprotein cholesterol (hs-CRP/HDL-C) index may be a potential indicator for MASLD and advanced liver fibrosis, given its relevance to inflammation and plasma lipids. In this study, the hs-CRP/HDL-C index was investigated in relation to prevalent MASLD and advanced liver fibrosis. The study analyzed secondary data from the National Health and Nutrition Examination Survey (NHANES) 2017–2018 database. The hs-CRP/HDL-C index was calculated by the quotient of hs-CRP and HDL-C. Multiple logistic regression models, Cochran-Armitage trend tests, smooth curve fitting, threshold effect analyses, and stratified analyses were used to evaluate whether the hs-CRP/HDL-C index associated with MASLD and advanced liver fibrosis. The study cohort comprised 3684 participants, of whom 1268 (34.42%) were diagnosed with MASLD and 156 (12.28%) with advanced liver fibrosis. Logistic analyses adjusted for covariates revealed positive associations of the hs-CRP/HDL-C index with MASLD and advanced liver fibrosis, consistent across all subgroups. Smooth curve fitting and threshold effect analyses revealed nonlinear relationships of hs-CRP/HDL-C index with MASLD and advanced liver fibrosis, with inflection points at 0.8 for MASLD and 1.2 for advanced liver fibrosis. Additionally, significant interactions were observed between MASLD and covariates such as gender, smoking status, chronic kidney disease (CKD), and cancer. Similarly, the hs-CRP/HDL-C index exhibited positive correlations with advanced liver fibrosis across diverse subgroups, with notable interactions related to cancer. MASLD and advanced liver fibrosis were associated with hs-CRP/HDL-C index, indicating its potential utility as a clinical marker for these conditions.
- 3 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-10
Open AccessNonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017–2018
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a globally widespread chronic liver condition that may progress to severe liver diseases, including advanced liver fibrosis. The high-sensitivity C-reactive protein-to-high-density lipoprotein cholesterol (hs-CRP/HDL-C) index may be a potential indicator for MASLD and advanced liver fibrosis, given its relevance to inflammation and plasma lipids. In this study, the hs-CRP/HDL-C index was investigated in relation to prevalent MASLD and advanced liver fibrosis. The study analyzed secondary data from the National Health and Nutrition Examination Survey (NHANES) 2017–2018 database. The hs-CRP/HDL-C index was calculated by the quotient of hs-CRP and HDL-C. Multiple logistic regression models, Cochran-Armitage trend tests, smooth curve fitting, threshold effect analyses, and stratified analyses were used to evaluate whether the hs-CRP/HDL-C index associated with MASLD and advanced liver fibrosis. The study cohort comprised 3684 participants, of whom 1268 (34.42%) were diagnosed with MASLD and 156 (12.28%) with advanced liver fibrosis. Logistic analyses adjusted for covariates revealed positive associations of the hs-CRP/HDL-C index with MASLD and advanced liver fibrosis, consistent across all subgroups. Smooth curve fitting and threshold effect analyses revealed nonlinear relationships of hs-CRP/HDL-C index with MASLD and advanced liver fibrosis, with inflection points at 0.8 for MASLD and 1.2 for advanced liver fibrosis. Additionally, significant interactions were observed between MASLD and covariates such as gender, smoking status, chronic kidney disease (CKD), and cancer. Similarly, the hs-CRP/HDL-C index exhibited positive correlations with advanced liver fibrosis across diverse subgroups, with notable interactions related to cancer. MASLD and advanced liver fibrosis were associated with hs-CRP/HDL-C index, indicating its potential utility as a clinical marker for these conditions.